Fisetin alleviates sepsis-induced multiple organ dysfunction in mice via inhibiting p38 MAPK/MK2 signaling.

Authors:
Zhang HF; Zhang HB; Wu XP; Guo YL; Cheng WD and 1 more

Journal:
Acta Pharmacol Sin

Publication Year: 2020

DOI:
10.1038/s41401-020-0462-y

PMCID:
PMC7608145

PMID:
32661350

Journal Information

Full Title: Acta Pharmacol Sin

Abbreviation: Acta Pharmacol Sin

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"This work was supported by the Natural Science Research Project of Education Office of Anhui Province (KJ2019A0300); The National Key Clinical Specialty Construction Project of Pulmonary Critical Care Medicine (2012–649); The Key Research and Development Program of Anhui Province (1804h08020287); and National Natural Science Foundation of China (81673791, 81973329, 81773741, and 81573438)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025